EcoR1 Capital’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-872,500
| Closed | -$7.72M | – | 34 |
|
|
2025
Q3 | $7.72M | Sell |
872,500
-3,327,500
| -79% | -$23.7M | 0.37% | 25 |
|
|
2025
Q2 | $24.2M | Buy |
4,200,000
+1,559,702
| +59% | +$9.56M | 1.43% | 15 |
|
|
2025
Q1 | $17.4M | Sell |
2,640,298
-916,971
| -26% | -$7.15M | 1.03% | 17 |
|
|
2024
Q4 | $31M | Sell |
3,557,269
-2,249,602
| -39% | -$32.4M | 1.17% | 19 |
|
|
2024
Q3 | $113M | Hold |
5,806,871
| – | – | 3.88% | 8 |
|
|
2024
Q2 | $120M | Hold |
5,806,871
| – | – | 3.66% | 9 |
|
|
2024
Q1 | $124M | Hold |
5,806,871
| – | – | 3.13% | 9 |
|
|
2023
Q4 | $83.5M | Hold |
5,806,871
| – | – | 2.17% | 13 |
|
|
2023
Q3 | $53M | Hold |
5,806,871
| – | – | 1.79% | 13 |
|
|
2023
Q2 | $61.4M | Sell |
5,806,871
-831,500
| -13% | -$9.83M | 1.51% | 15 |
|
|
2023
Q1 | $81.2M | Hold |
6,638,371
| – | – | 2.61% | 13 |
|
|
2022
Q4 | $82.4M | Hold |
6,638,371
| – | – | 2.51% | 12 |
|
|
2022
Q3 | $90.7M | Hold |
6,638,371
| – | – | 2.68% | 12 |
|
|
2022
Q2 | $122M | Hold |
6,638,371
| – | – | 4.2% | 9 |
|
|
2022
Q1 | $107M | Buy |
6,638,371
+2,913,934
| +78% | +$42.1M | 3.34% | 9 |
|
|
2021
Q4 | $52.1M | Hold |
3,724,437
| – | – | 1.66% | 17 |
|
|
2021
Q3 | $69.8M | Hold |
3,724,437
| – | – | 2.43% | 12 |
|
|
2021
Q2 | $77.7M | Buy |
3,724,437
+31,800
| +0.9% | +$789K | 2.9% | 11 |
|
|
2021
Q1 | $104M | Buy |
3,692,637
+1,919,600
| +108% | +$60.7M | 4.63% | 8 |
|
|
2020
Q4 | $57.9M | Sell |
1,773,037
-2,835,492
| -62% | -$99.6M | 3.11% | 12 |
|
|
2020
Q3 | $141M | Hold |
4,608,529
| – | – | 10.07% | 2 |
|
|
2020
Q2 | $75.1M | Buy |
4,608,529
+1,096,839
| +31% | +$15.8M | 5.55% | 5 |
|
|
2020
Q1 | $34.9M | Sell |
3,511,690
-730,263
| -17% | -$8.36M | 3.65% | 11 |
|
|
2019
Q4 | $58.3M | Buy |
4,241,953
+200,000
| +5% | +$2.96M | 5.26% | 5 |
|
|
2019
Q3 | $61.3M | Sell |
4,041,953
-1,234,800
| -23% | -$22M | 7.74% | 4 |
|
|
2019
Q2 | $104M | Hold |
5,276,753
| – | – | 10.5% | 1 |
|
|
2019
Q1 | $87.5M | Hold |
5,276,753
| – | – | 8.07% | 2 |
|
|
2018
Q4 | $74.1M | Buy |
5,276,753
+1,373,778
| +35% | +$18.2M | 7.41% | 2 |
|
|
2018
Q3 | $68.3M | Sell |
3,902,975
-1,700
| -0% | -$32.6K | 6.15% | 5 |
|
|
2018
Q2 | $71.1M | Buy |
3,904,675
+137,823
| +4% | +$2.33M | 6.77% | 5 |
|
|
2018
Q1 | $70.6M | Hold |
3,766,852
| – | – | 7.08% | 5 |
|
|
2017
Q4 | $57.6M | Hold |
3,766,852
| – | – | 6.49% | 6 |
|
|
2017
Q3 | $56.3M | Buy |
3,766,852
+1,733,230
| +85% | +$16.3M | 7.51% | 5 |
|
|
2017
Q2 | $18.9M | Sell |
2,033,622
-578,284
| -22% | -$5.26M | 3.36% | 9 |
|
|
2017
Q1 | $23M | Hold |
2,611,906
| – | – | 5.81% | 6 |
|
|
2016
Q4 | $15.4M | Hold |
2,611,906
| – | – | 4.91% | 8 |
|
|
2016
Q3 | $16.3M | Buy |
2,611,906
+146,620
| +6% | +$743K | 5.01% | 7 |
|
|
2016
Q2 | $6.68M | Hold |
2,465,286
| – | – | 2.63% | 14 |
|
|
2016
Q1 | $9.98M | Buy |
2,465,286
+15,286
| +0.6% | +$72.5K | 3.49% | 13 |
|
|
2015
Q4 | $20.6M | Buy |
+2,450,000
| New | +$19.3M | 6.46% | 6 |
|
Other funds holding KURA
BI
SCM
AC
PM
EcoR1 Capital's KURA Position: Q4 2025 in Review
EcoR1 Capital sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 872,500 shares — an estimated $7.72M sold.
EcoR1 Capital first reported a position in KURA in Q4 2015 and held it in 40 quarters. The position peaked at $141M in Q3 2020. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.
- EcoR1 Capital reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
- EcoR1 Capital sold 872,500 Kura Oncology shares in Q4 2025, an estimated $7.72M.
- EcoR1 Capital first reported a position in Kura Oncology in Q4 2015 and held it in 40 quarters.
- EcoR1 Capital's Kura Oncology position peaked at $141M in Q3 2020.
- 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.
Based on EcoR1 Capital's 13F filing for Q4 2025, filed 17 Feb 2026.